Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 31, 2018

View Archived Issues

Renin inhibitor TAK-272 developed at Takeda for heart failure

PLIN2 is a putative tumor suppressor and prognostic marker of renal cell carcinoma

New preterm labor is drug safe with favorable pharmacokinetic profile

FDA approves Jivi for hemophilia A

Thanks for the memories: In bacteria, protein aggregates can protect from stress

Pfizer terminates two ongoing domagrozumab studies for DMD

Bristol-Myers Squibb patents receptor-interacting serine/threonine-protein kinase 1 inhibitors

Novel cardiac biomarkers identified for heart failure, myocardial infarction

Seven genes linked to plaque rupture in STEMI

Xenon Pharmaceuticals tests antiepileptic NaV1.6 inhibitors in vivo

European Commission approves Onpattro for hATTR with polyneuropathy

First patient enrolled in phase IIb/III trial of Anavex 2-73 for early Alzheimer's disease

FDA approves Merck & Co.'s Delstrigo and Pifeltro for the treatment of HIV-1

PolyActiva commences its first phase I trial of glaucoma treatment

Computational analysis uncovers mechanisms to enhance the efficacy of anti-cancer immunotherapy

MicroRNA-30c-5p identified as a potential therapeutic target and biomarker of neuropathic pain

Update on TULIP 1 phase III trial for anifrolumab in systemic lupus erythematosus

Cynata stem cell therapy meets safety and efficacy endpoints in phase I trial in GvHD

EC approves Tafinlar + Mekinist for adjuvant treatment of BRAF V600 mutation-positive melanoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...